IN BRIEF: Beximco To Be Exclusive Covid Vaccine Supplier In Bangladesh

Fri, 28th Aug 2020 14:33

Beximco Pharmaceuticals PLC - Bangladesh-based medicine manufacturer - Partners with vaccine producer Serum Institute of India Pvt Ltd on cooperation and distribution agreement to develop Covid-19 vaccine, for which Beximco will be the exclusive supplier in Bangladesh. Serum has partnered with AsstraZeneca PLC, Gates Foundation and Gavi to producer more than billion doses of a vaccine for global supply.

Current stock price: 60.25 pence

Year-to-date change: up 31%

By Dayo Laniyan; dayolaniyan@alliancenews.com

Related Shares

More News

Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...